Vol 55, No 4 (2024)
Editorial
Published online: 2024-08-31
A breakthrough in lymphoma therapy
DOI: 10.5603/ahp.102328
Acta Haematol Pol 2024;55(4):185.
Abstract
Not available
References
- Danecki M, Jurczak W. Bispecific antibodies in relapsed/refractory diffuse large B-cell lymphoma. Acta Haematol Pol. 2024; 55(4): 186–191.
- Kubicki T, Adamska M, Żyłka K, et al. Therapy-related myeloid malignancies in patients with multiple myeloma. Acta Haematol Pol. 2024; 55(4): 192–201.
- Styczyński J, Pogorzała M, Sadlok J. Tabelecleucel: a new therapeutic option in refractory EBV-PTLD. Acta Haematol Pol. 2024; 55(4): 202–208.